日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.

雌激素受体阳性细胞系异种移植模型重现了浸润性小叶乳腺癌的转移扩散和内分泌反应。

Tasdemir Nilgun, Savariau Laura, Scott Julie, Latoche Joseph D, Biery Kyle, Li Zheqi, Bossart Emily A, Sreekumar Sreeja, Brown Daniel D, Wang Sarah, Watters Rebecca J, Nasrazadani Azadeh, Qin Ye, Cao Ye, Chen Fangyuan, Tseng George, Castro Carlos, Anderson Carolyn J, Atkinson Jennifer, Hooda Jagmohan, Lucas Peter C, Davidson Nancy E, Lee Adrian V, Oesterreich Steffi

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

新辅助化疗后若疗效显著,可省略区域淋巴结照射

Mamounas, Eleftherios P; Bandos, Hanna; White, Julia R; Julian, Thomas B; Khan, Atif J; Shaitelman, Simona F; Torres, Mylin A; Vicini, Frank A; Ganz, Patricia A; McCloskey, Susan A; Lucas, Peter C; Gupta, Nilendu; Li, X Allen; McCormick, Beryl; Smith, Benjamin; Tendulkar, Rahul D; Kavadi, Vivek S; Matsumoto, Koji; Seaward, Samantha Andrews; Irvin, William J Jr; Lin, Jolinta Y; Mutter, Robert W; Muanza, Thierry M; Stromberg, Jannifer; Jagsi, Reshma; Weiss, Anna C; Curran, Walter J Jr; Wolmark, Norman

Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial

乳腺肿瘤床活检用于病理完全缓解预测:NRG-BR005 非随机临床试验

Basik, Mark; Cecchini, Reena S; De Los Santos, Jennifer F; Umphrey, Heidi R; Julian, Thomas B; Mamounas, Eleftherios P; White, Julia R; Lucas, Peter C; Balanoff, Christa R; Tan, Antoinette R; Weber, Joseph J; Edmonson, David A; Brown-Glaberman, Ursa A; Diego, Emilia J; Teshome, Mediget; Matsen, Cindy B; Seaward, Samantha A; Wapnir, Irene L; Wagner, Jamie L; Tjoe, Judy A; Thompson, Alastair M; Wolmark, Norman

A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma.

BCL10-MALT1相互作用的小分子抑制剂可阻止弥漫性大B细胞淋巴瘤的进展

Kang Heejae, Maurer Lisa M, Cheng Jing, Smyers Mei, Klei Linda R, Hu Dong, Hofstatter Azambuja Juliana, Murai Marcelo J, Mady Ahmed, Ahmad Ejaz, Trotta Matthew, Klei Hanna B, Liu Minda, Ekambaram Prasanna, Nikolovska-Coleska Zaneta, Chen Bill B, McAllister-Lucas Linda M, Lucas Peter C

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial

70基因MammaPrint检测在NRG Oncology/NSABP B-42试验中预测延长来曲唑治疗获益的效用

Rastogi, Priya; Bandos, Hanna; Lucas, Peter C; van 't Veer, Laura J; Wei, Jia-Perng J; Geyer, Charles E Jr; Fehrenbacher, Louis; Chia, Stephen K L; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker R; Paik, Soonmyung; Swain, Sandra M; Menicucci, Andrea R; Audeh, M William; Wolmark, Norman; Mamounas, Eleftherios P

Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer

机器学习预测奥沙利铂对早期结肠癌的疗效

Chen, Lujia; Wang, Ying; Cai, Chunhui; Ding, Ying; Kim, Rim S; Lipchik, Corey; Gavin, Patrick G; Yothers, Greg; Allegra, Carmen J; Petrelli, Nicholas J; Suga, Jennifer Marie; Hopkins, Judith O; Saito, Naoyuki G; Evans, Terry; Jujjavarapu, Srinivas; Wolmark, Norman; Lucas, Peter C; Paik, Soonmyung; Sun, Min; Pogue-Geile, Katherine L; Lu, Xinghua

Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials

早期ERBB2/HER2阳性乳腺癌的肿瘤内在亚型和基因表达特征:CALGB 40601、NeoALTTO和NSABP B-41试验的汇总分析

Fernandez-Martinez, Aranzazu; Rediti, Mattia; Tang, Gong; Pascual, Tomás; Hoadley, Katherine A; Venet, David; Rashid, Naim U; Spears, Patricia A; Islam, Md N; El-Abed, Sarra; Bliss, Judith; Lambertini, Matteo; Di Cosimo, Serena; Huobe, Jens; Goerlitz, David; Hu, Rong; Lucas, Peter C; Swain, Sandra M; Sotiriou, Christos; Perou, Charles M; Carey, Lisa A

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

来自 NRG Oncology/NSABP B-42 试验的乳腺癌指数和芳香化酶抑制剂治疗激素受体阳性乳腺癌患者长期获益的预测

Mamounas, Eleftherios P; Bandos, Hanna; Rastogi, Priya; Zhang, Yi; Treuner, Kai; Lucas, Peter C; Geyer, Charles E Jr; Fehrenbacher, Louis; Chia, Stephen K; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker; Paik, Soonmyung; Swain, Sandra M; Sgroi, Dennis C; Schnabel, Catherine A; Wolmark, Norman

Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer

免疫浸润与原发性雌激素受体阳性浸润性小叶癌的转录组亚型相关

Chen, Fangyuan; Onkar, Sayali; Zou, Jian; Li, Yujia; Arbore, Haley; Maley, Sai; Tseng, George; Lucas, Peter C; Bruno, Tullia C; Vignali, Dario A A; Foldi, Julia; Balic, Marija; Lee, Adrian V; Oesterreich, Steffi

NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer

NSABP FB-10:一项评估ado-trastuzumab emtansine (T-DM1)联合neratinib治疗HER2阳性转移性乳腺癌女性患者的Ib/II期临床试验

Jacobs, Samuel A; Wang, Ying; Abraham, Jame; Feng, Huichen; Montero, Alberto J; Lipchik, Corey; Finnigan, Melanie; Jankowitz, Rachel C; Salkeni, Mohamad A; Maley, Sai K; Puhalla, Shannon L; Piette, Fanny; Quinn, Katie; Chang, Kyle; Nagy, Rebecca J; Allegra, Carmen J; Vehec, Kelly; Wolmark, Norman; Lucas, Peter C; Srinivasan, Ashok; Pogue-Geile, Katherine L